| Literature DB >> 26456931 |
Natsuo Yamamoto1,2, Steven M Kerfoot1, Andrew T Hutchinson1, Charles S Dela Cruz1, Naomi Nakazawa2, Marian Szczepanik1,3, Monika Majewska-Szczepanik1,3, Katarzyna Nazimek1,4, Noboru Ohana2, Krzysztof Bryniarski1,4, Tsutomu Mori2, Masamichi Muramatsu5, Keiji Kanemitsu2, Philip W Askenase1.
Abstract
We describe a protective early acquired immune response to pneumococcal pneumonia that is mediated by a subset of B1a cells. Mice deficient in B1 cells (xid), or activation-induced cytidine deaminase (AID(-/-) ), or invariant natural killer T (iNKT) cells (Jα18(-/-) ), or interleukin-13 (IL-13(-/-) ) had impaired early clearance of pneumococci in the lung, compared with wild-type mice. In contrast, AID(-/-) mice adoptively transferred with AID(+/+) B1a cells, significantly cleared bacteria from the lungs as early as 3 days post infection. We show that this early bacterial clearance corresponds to an allergic contact sensitivity-like cutaneous response, probably due to a subpopulation of initiating B1a cells. In the pneumonia model, these B1a cells were found to secrete higher affinity antigen-specific IgM. In addition, as in contact sensitivity, iNKT cells were required for the anti-pneumococcal B1a cell initiating response, probably through early production of IL-13, given that IL-13(-/-) mice also failed to clear infection. Our study is the first to demonstrate the importance of AID in generating an appropriate B1a cell response to pathogenic bacteria. Given the antibody affinity and pneumonia resistance data, natural IgM produced by conventional B1a cells are not responsible for pneumonia clearance compared with the AID-dependent subset.Entities:
Keywords: B1a cells; IgM antibody; activation-induced cytidine deaminase; interleukin-13; invariant natural killer T cells; pneumococcal pneumonia
Mesh:
Substances:
Year: 2016 PMID: 26456931 PMCID: PMC4693878 DOI: 10.1111/imm.12544
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397